Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.510 Biomarker group CTD_mouse Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination. 10850423 2000
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.510 Biomarker group BEFREE We examined p53 protein expression, p53 gene mutation, proliferating cell nuclear antigen (PCNA), and argyrophilic nuclear organizer regions (AgNOR), in 30 patients with surgically-treated thymic tumors (26 thymoma and 4 thymic carcinoma cases). p53 expression ratio with DO-1 was divided as p53 negative (0% positivity), low expressor (<10% positivity), high expressor (>10% positivity). 9852302 1998
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.510 GenomicAlterations group CGI
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.510 CausalMutation group CGI
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.300 Biomarker group CTD_human Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1. 28736328 2017
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.300 CausalMutation group CGI
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.300 CausalMutation group CGI
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.110 Biomarker group BEFREE Lymphoma-prone AKT2-transgenic or PTEN-deficient mice on an Rpl22(-/-) background developed significantly larger and markedly more vascularized thymic tumors than those observed in Rpl22(+/+) control mice. 27197189 2016
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.110 Biomarker group HPO
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.100 Biomarker group HPO
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2
0.100 CausalMutation group CLINVAR
Entrez Id: 3956
Gene Symbol: LGALS1
LGALS1
0.010 AlteredExpression group BEFREE Expression of galectin-1 in thymic tumor was compared to benign thymus controls and correlated with pertinent clinical and pathologic data. 30773448 2019
Entrez Id: 2130
Gene Symbol: EWSR1
EWSR1
0.010 GeneticVariation group BEFREE Because the immunophenotype is unspecific, testing for the EWSR1 translocation might be helpful in discriminating this entity from other thymic neoplasms or metastases, in particular those with clear cell change. 31050844 2019
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.010 Biomarker group BEFREE Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes. 28718205 2018
Entrez Id: 208
Gene Symbol: AKT2
AKT2
0.010 Biomarker group BEFREE Lymphoma-prone AKT2-transgenic or PTEN-deficient mice on an Rpl22(-/-) background developed significantly larger and markedly more vascularized thymic tumors than those observed in Rpl22(+/+) control mice. 27197189 2016
Entrez Id: 6146
Gene Symbol: RPL22
RPL22
0.010 Biomarker group BEFREE Lymphoma-prone AKT2-transgenic or PTEN-deficient mice on an Rpl22(-/-) background developed significantly larger and markedly more vascularized thymic tumors than those observed in Rpl22(+/+) control mice. 27197189 2016
Entrez Id: 2067
Gene Symbol: ERCC1
ERCC1
0.010 GeneticVariation group BEFREE We aimed to analyze genotypes of VEGF-A, VEGFR2, Flt4, PDGFRα, HIF-1α and ERCC1 and their correlation with thymic tumor risk and patient outcome. 26254278 2015
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.010 GeneticVariation group BEFREE At the medical follow-up, the thymic tumor had spontaneously regressed; however, identification of oncogenic BRAF mutation supports the neoplastic nature of the current case. 24703101 2014
Entrez Id: 7153
Gene Symbol: TOP2A
TOP2A
0.010 AlteredExpression group BEFREE Low TS and, to a minor extent, RRM1 and TOP2A expression were detected in aggressive thymic tumors. 23276504 2013
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.010 AlteredExpression group BEFREE Low TS and, to a minor extent, RRM1 and TOP2A expression were detected in aggressive thymic tumors. 23276504 2013
Entrez Id: 6240
Gene Symbol: RRM1
RRM1
0.010 AlteredExpression group BEFREE Low TS and, to a minor extent, RRM1 and TOP2A expression were detected in aggressive thymic tumors. 23276504 2013
Entrez Id: 51540
Gene Symbol: SCLY
SCLY
0.010 AlteredExpression group BEFREE We compared the gene expression pattern of thymic tumors from precursor T-cell lymphoblastic lymphoma/leukemia (pre-T LBL) that arose in transgenic mice that overexpressed SCL, LMO1 or NUP98-HOXD13 (NHD13) with that of thymocytes from normal littermates. 17429429 2007
Entrez Id: 6886
Gene Symbol: TAL1
TAL1
0.010 AlteredExpression group BEFREE We compared the gene expression pattern of thymic tumors from precursor T-cell lymphoblastic lymphoma/leukemia (pre-T LBL) that arose in transgenic mice that overexpressed SCL, LMO1 or NUP98-HOXD13 (NHD13) with that of thymocytes from normal littermates. 17429429 2007
Entrez Id: 3855
Gene Symbol: KRT7
KRT7
0.010 AlteredExpression group BEFREE We compared the gene expression pattern of thymic tumors from precursor T-cell lymphoblastic lymphoma/leukemia (pre-T LBL) that arose in transgenic mice that overexpressed SCL, LMO1 or NUP98-HOXD13 (NHD13) with that of thymocytes from normal littermates. 17429429 2007
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.010 AlteredExpression group BEFREE Gene expression profiling of thymic tumors that developed in OLIG2/LMO1 mice revealed up-regulation of Notch1 as well as Deltex1 (Dtx1) and pre T-cell antigen receptor alpha (Ptcra), two genes that are considered to be downstream of Notch1. 16103065 2005